^
TNFRSF8 expression
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
belinostat
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
ALK positive
Peripheral T-cell Lymphoma
crizotinib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
etoposide IV
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
cyclophosphamide oral
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
etoposide IV + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bortezomib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bendamustine
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
alemtuzumab
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
lenalidomide
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
gemcitabine
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
pralatrexate
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
RP6530
Sensitive
:
B
IL2RA expression
Peripheral T-cell Lymphoma
denileukin diftitox
Sensitive
:
C1
PD-L1 overexpression
Peripheral T-cell Lymphoma
GB226
Sensitive
:
C3
PD-1 overexpression
Peripheral T-cell Lymphoma
nivolumab
Sensitive
:
C3
RHOA mutation
Peripheral T-cell Lymphoma
copanlisib
Sensitive
:
C3
IDH2 mutation
Peripheral T-cell Lymphoma
copanlisib
Sensitive
:
C3
TSC2 mutation
Peripheral T-cell Lymphoma
copanlisib
Sensitive
:
C3
TNFRSF8 positive
Peripheral T-cell Lymphoma
BV-ICE
Sensitive
:
C3
IL10-H
Peripheral T-cell Lymphoma
CHOP
Resistant
:
C3
RPS6 underexpression
Peripheral T-cell Lymphoma
ruxolitinib
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our